ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2025-13703

VIPRE Advanced Security Incorrect Permission Assignment Local Privilege Escalation Vulnerability.

Published Dec 23, 2025 · catalog updated Jan 2, 2026 · VIPRE Advanced Security

Last checked Nov 2, 2026. A connected source was read within the last 7 days.

Check if you run it

No confirmed exploitation is on record for CVE-2025-13703. EPSS is 0.14%. Act only if a listed version of VIPRE Advanced Security is installed.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
High7.8
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.14%
Remediation
Vendor / distro source
Affected products
vendor VIPRE Advanced Security 12.0.2.220

VIPRE Advanced Security Incorrect Permission Assignment Local Privilege Escalation Vulnerability. This vulnerability allows local attackers to escalate privileges on affected installations of VIPRE Advanced Security for PC. An attacker must first obtain the ability to execute low-privileged code on the target system in order to exploit this vulnerability. The specific flaw exists within the product installer. The issue results from incorrect permissions on a folder. An attacker can leverage this vulnerability to escalate privileges and execute arbitrary code in the context of SYSTEM. Was ZDI-C

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor VIPRE Advanced Security 12.0.2.22012.0.2.220

How to fix CVE-2025-13703

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2025-13703. EPSS is 0.14%. Act only if a listed version of VIPRE Advanced Security is installed.

Which versions are affected?

Compare what you have installed with VIPRE Advanced Security 12.0.2.220 12.0.2.220. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 0.14%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Dec 23, 2025 · EUVD

    Detected

    VIPRE Advanced Security Incorrect Permission Assignment Local Privilege Escalation Vulnerability. This vulnerability allows local attackers to escalate privileges on affected installations of VIPRE Advanced Security for PC. An attacker must first obtain the ability to execute low-privileged code on the target system in order to exploit this vulnerability. The specific flaw exists within the produc

  2. Jan 2, 2026 · EUVD

    Updated

    VIPRE Advanced Security Incorrect Permission Assignment Local Privilege Escalation Vulnerability. This vulnerability allows local attackers to escalate privileges on affected installations of VIPRE Advanced Security for PC. An attacker must first obtain the ability to execute low-privileged code on the target system in order to exploit this vulnerability. The specific flaw exists within the produc

Sources

  • CVE.orgVulnerability recordCVE-2025-13703

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2025-13703

    30-day exploitation probability 0.14%

    first.org
  • EUVDVulnerability recordEUVD-2025-204984

    VIPRE Advanced Security Incorrect Permission Assignment Local Privilege Escalation Vulnerability. This vulnerability allows local attackers to escalate privileges on affected installations of VIPRE Advanced Security for PC. An attacker must first obtain the ability to execute low

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog Nov 2, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.

  • FIRST EPSSNov 2, 2026
  • CVE.orgNov 2, 2026
  • EUVDNov 1, 2026